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RESEARCH IN CONTEXT 
 
Evidence before this study 
We searched Medline (through PubMed) up to January 2018 in order to identify relevant cohort studies as 
well as systematic reviews that focused on the associations of gestational diabetes and hypertensive 
disorders of pregnancy with offspring obesity and the role of maternal obesity in these associations. Our 
search was a combination of the key words [free text and MeSH (Medical Subject Headings) terms] 
related to our exposures (gestational diabetes OR gestational hypertension OR pre-eclampsia) and 
outcomes (overweight OR obesity OR body mass index OR adiposity). We were able to identify several 
systematic reviews and some prospective cohort studies, that varied in terms of methodological quality. 
Gestational diabetes and gestational hypertensive disorders are common pregnancy complications 
associated with increased risks of perinatal mortality and morbidity, and seem to influence the risk of 
obesity in the offspring. Maternal obesity is a major risk factor for common pregnancy complications, and 
is also associated with an increased risk of obesity in the offspring. However, it is not clear whether 
gestational diabetes and gestational hypertensive disorders affect the risk of offspring obesity 
independently of the risk conferred by maternal obesity.  
Added value of this study 
We performed an individual participant data meta-analysis of 160757 mother-offspring pairs from 34 
prospective European or North-American contemporary pregnancy/birth cohorts. We observed that 
children born to mothers with gestational diabetes and gestational hypertension had a higher BMI and 
higher odds of being overweight throughout childhood. Pre-eclampsia was associated with a lower BMI 
in early-childhood. All associations were largely explained by maternal pre/early-pregnancy BMI. Our 
study strongly suggests that the previously observed associations of common pregnancy complications 
with higher offspring BMI are largely explained by maternal BMI. 
Implications of all the available evidence 
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Lowering maternal risk of gestational diabetes, gestational hypertension and pre-eclampsia, though 
important in relation to maternal and fetal pregnancy outcomes, is unlikely to have a direct impact on 
offspring obesity among Western women receiving contemporary medical care. Preventive strategies for 
reducing childhood obesity should focus on maternal BMI rather than on pregnancy complications. 
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SUMMARY  
Background: Gestational diabetes and gestational hypertensive disorders are associated with offspring 
obesity. The role of maternal adiposity in these associations remains unclear. We aimed to evaluate if 
these pregnancy complications affect the odds of offspring obesity independently of maternal obesity.  
Methods: In this individual participant data meta-analysis of 160757 mother-offspring pairs from 34 
prospective European or North-American pregnancy/birth cohorts, we assessed the associations of 
gestational diabetes, gestational hypertension and pre-eclampsia with childhood BMI and the odds of 
overweight and obesity throughout childhood. We explored to what extent any association was explained 
by maternal pre/early-pregnancy BMI. 
Findings: Gestational diabetes was associated with a higher odds of overweight throughout childhood 
(Odds Ratio (OR) 1·59 (95% Confidence Intervals (CI) 1·36, 1·86); OR 1·41 (95% CI 1·26, 1·57); OR 
1·32 (95% CI 0·99, 1·78) for early-, mid- and late-childhood, respectively) when compared to 
uncomplicated pregnancies. These associations attenuated towards the null following adjustment for 
maternal BMI. Likewise, gestational hypertension was associated with a higher odds of overweight 
throughout childhood, with the strongest association in late-childhood (OR 1·49 (95% CI 1·30, 1·70)), 
when compared to uncomplicated pregnancies. Additional adjustment for maternal BMI largely explained 
these associations. Pre-eclampsia was associated with a lower BMI in early-childhood only (difference in 
BMI-SDS - 0.05 SDS (95% CI - 0·09, - 0·01)), when compared to uncomplicated pregnancies. This 
association strengthened upon additional adjustment for maternal BMI. 
Interpretation: Our results suggest that lowering maternal risk of gestational diabetes and hypertensive 
disorders is unlikely to have a direct impact on childhood obesity. Preventive strategies for reducing 
childhood obesity should focus on maternal BMI rather than on pregnancy complications. 
 
Funding:  This work was supported by the European Union's Horizon 2020 research and innovation 
programme under grant agreement 733206 (LifeCycle Project).
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INTRODUCTION 1 
Gestational diabetes and gestational hypertensive disorders are among the most common pregnancy 2 
complications, affecting 10-25% and 2-4% of all pregnancies, respectively.
1,2
 These complications are 3 
major risk factors for maternal and fetal morbidity and mortality.
1-3
 Overall, 12% of maternal deaths are 4 
attributable to gestational hypertensive disorders, whereas up to 10% of adverse fetal outcomes, such as 5 
delivering a large size for gestational age infant are attributable to gestational diabetes.
4-6
  Fetal exposure 6 
to hyperglycemia due to gestational diabetes or altered utero-placental perfusion due to gestational 7 
hypertension and pre-eclampsia affect fetal nutrient supply.
7,8
 Alterations in the fetal supply line may 8 
influence fetal development, and trigger developmental adaptations in adipose tissue, neuroendocrine and 9 
metabolic function, which could predispose offspring to adiposity in later life.
9
  10 
Maternal obesity is a risk factor for gestational diabetes and gestational hypertensive disorders, 11 
and is also associated with an increased risk of obesity in offspring.
10
 It is not clear whether gestational 12 
diabetes and gestational hypertensive disorders affect the risk of offspring obesity independently of the 13 
risk conferred by maternal obesity. Previous studies have shown that diabetes during pregnancy is 14 
associated with an increased risk of offspring obesity and higher fat mass levels, independent of maternal 15 
socio-demographic and lifestyle characteristics.
11-17
 Inconsistent findings were reported for the specific 16 
role of maternal obesity in these associations. Prospective cohort studies have assessed the relations of 17 
gestational hypertensive disorders with offspring blood pressure, but only few have also assessed the 18 
relation with offspring adiposity.
18-20
 A UK study reported that children of women who had either 19 
gestational hypertension or pre-eclampsia had higher risk of obesity at 9 years, whereas an Australian 20 
study found similar associations only in term born young adults of mothers with gestational hypertension, 21 
but not with pre-eclampsia.
18,19 
For the development of new preventive strategies focused on reducing 22 
childhood obesity, insight into the effects of gestational diabetes and gestational hypertensive disorders, 23 
independent of maternal obesity, on offspring obesity is needed. 24 
Using individual participant data (IPD) from 160757 mother-offspring pairs, we assessed the 25 
associations of maternal gestational diabetes, gestational hypertension and pre-eclampsia with the odds of 26 
6 
 
offspring overweight and obesity throughout childhood. We further explored whether any observed 27 
association was independent of maternal pre-/early-pregnancy BMI. 28 
 29 
METHODS 30 
 31 
Inclusion criteria and participating cohorts 32 
We used data from an existing international collaboration on maternal obesity and childhood outcomes. 33 
Pregnancy and birth cohort studies were eligible for inclusion in this international collaboration if they 34 
were able to provide IPD on mothers with singleton live-born children born from 1989 onwards, and had 35 
information available on maternal pre/early-pregnancy BMI and birth weight and/or childhood BMI. We 36 
invited 50 cohorts from Europe, North America and Oceania identified from existing collaborations on 37 
childhood health (EarlyNutrition Project, CHICOS Project, www.birthcohorts.net; last accessed July 38 
2014), of which 38 agreed to participate and provided data on 274174 singleton births. For this study, we 39 
only included cohorts that were able to provide IPD on maternal gestational diabetes, gestational 40 
hypertension or pre-eclampsia, and childhood BMI obtained at least once between age 2 and 17·9 years. 41 
This resulted in 160757 mothers-offspring pairs available for analysis (Supplemental Figure S1). 42 
Anonymized datasets were stored on a single central secured data server with access for the main analysts 43 
(BPG, SS). All studies were approved by their local institutional review boards. Additional ethics 44 
approval was not required to perform this IPD meta-analysis. 45 
 46 
Pregnancy complications and pre/early-pregnancy BMI 47 
Information on gestational diabetes, gestational hypertension, pre-eclampsia and maternal BMI was 48 
obtained from medical records, through research assessments or was self-reported (cohort-specific 49 
information is shown in Supplemental Table S1). Where possible we used maternal pre-pregnancy BMI 50 
(<18·5, 18·5 - <25, 25 - <30, ≥30 kg/m2). Five cohorts (including 6,513 participants) did not have 51 
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information about pre-pregnancy BMI but obtained BMI in early pregnancy (all assessed before or at 20 52 
weeks of gestation). 53 
 54 
Childhood BMI 55 
Data on childhood weight and height were mostly obtained through direct research assessments, with a 56 
small number of studies abstracting information about weight and height, or BMI, from medical records, 57 
report by parents/caregivers or self-reported (cohort-specific information is provided in Supplemental 58 
Table S1). We grouped BMI based on the child’s age at assessment into early-childhood (2·0–4·9 years), 59 
mid-childhood (5·0–9·9 years), and late-childhood (10·0–17·9 years). The age intervals, which correspond 60 
roughly to preschoolers, school-age children and adolescents, respectively, were predefined based on data 61 
availability and data for each period were provided by the cohorts. If studies had multiple repeated 62 
measurements within the same age period, we used data collected at the oldest age. We calculated sex- 63 
and age-adjusted standard deviation scores (SDS) of childhood BMI using WHO reference growth charts 64 
(Growth Analyzer 4·0, Dutch Growth Research Foundation).21-24 Childhood underweight, normal weight, 65 
overweight and obesity (further referred as overweight) were defined based on the age- and sex- specific 66 
WHO criteria.21,22 67 
 68 
Covariates 69 
Covariates were mostly obtained by questionnaires and provided by cohorts as categorical variables 70 
(cohort-specific information is shown in Supplemental Table S1 and S2). To allow handling of missing 71 
data, the continuous covariates were categorized. As potential confounders other than maternal pre-72 
pregnancy BMI, we considered maternal age (defined based on data availability: <25·0 years, 25-29·9 73 
years, 30-34·9 years, ≥35·0 years), educational level (low, medium, high), ethnicity (European/White, 74 
non-European/non-White), parity (nulliparous, multiparous), smoking during pregnancy (yes, no), and 75 
offspring’s sex. We did not adjust the primary analyses for offspring birth weight and gestational age at 76 
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delivery, as these birth characteristics are likely to be mediators on the causal pathway and adjustment 77 
might introduce bias.
25
  78 
 79 
Statistical analysis 80 
We assessed the percentage of childhood overweight in early, mid and late childhood for each combined 81 
maternal BMI and pregnancy complication group. We applied multilevel mixed effects models, taking 82 
into account clustering of participants within cohorts, to analyze simultaneously IPD from all cohorts.
26
 83 
Our models were defined assuming a random intercept at cohort level, which allowed for differences in 84 
the intercepts between cohorts. First, we used multilevel linear mixed effects models to examine the 85 
associations of gestational diabetes, gestational hypertension or pre-eclampsia with BMI SDS in early-, 86 
mid-, and late-childhood. Second, we used multilevel binary logistic mixed effects models to examine the 87 
associations of these pregnancy complications with the odds of childhood underweight, and overweight in 88 
the same age windows. Participants exposed to either gestational hypertension or pre-eclampsia were 89 
compared to those with none of these conditions, irrespective of their gestational diabetes status. 90 
Similarly, those exposed to gestational diabetes were compared to those with no gestational diabetes, 91 
irrespective of whether or not they had gestational hypertension or pre-eclampsia. For all analyses, we 92 
constructed an unadjusted model (Basic model), a model adjusted for offspring’s sex, maternal age, 93 
educational level, ethnicity, parity and smoking during pregnancy (Lifestyle characteristics model), and a 94 
model additionally adjusted for maternal pre/early-pregnancy BMI (Maternal BMI model).  For the 95 
associations of pregnancy complications with the odds of childhood underweight, only the basic model 96 
was applied due to insufficient sample size. Based on findings from previous studies and clinical 97 
relevance, we tested potential interactions between each pregnancy complication and (i) offspring´s sex 98 
and (ii) maternal BMI, in their associations with childhood BMI.
27-29
 Since no consistent significant 99 
interactions were observed, no further stratified analyses were performed. To prevent exclusion of non-100 
complete cases, we used missing values in the covariates as an additional group (percentage missings per 101 
cohort given in Supplemental Table S2). We did not include information for a cohort for a specific 102 
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categorical covariate, if information for this variable was available for less than 50% of the cohort sample. 103 
Due to the strategy used to handle missing data, the confounding factors were included in the models as 104 
categorical covariates. However, in an analysis using complete cases of maternal pre-pregnancy BMI and 105 
age, similar associations were observed when adjusting for them as continuous or categorical covariates 106 
(Supplemental Table S3). As sensitivity analysis, we performed 2-stage random effects meta-analyses and 107 
tested for heterogeneity between cohorts using the I
2
.
26
 Analyses were undertaken using the Statistical 108 
Package of Social Sciences version 21.0 for Windows (SPSS Inc, Chicago, IL, USA) and Review 109 
Manager ((RevMan) Version [5.3.5]. Copenhagen: The Nordic Cochrane Centre, The Cochrane Collaboration, 110 
2014) software. 111 
 112 
Role of the funding source 113 
This work was supported by the European Union's Horizon 2020 research and innovation programme 114 
under grant agreement 733206 (LifeCycle Project). The funding source had no role in the study design, 115 
data collection, analysis, interpretation, and in the writing of the report. BPG and SS had access to the raw 116 
data. The corresponding author had full access to all of the data and the final responsibility to submit for 117 
publication. 118 
 119 
RESULTS 120 
 121 
Response and subject characteristics 122 
Out of 50 cohorts identified and invited, 38 agreed to participate and 34 were included in these analyses. 123 
Only 4 cohorts (113417 participants) were excluded due to missing data on exposures and/or outcomes. 124 
Table 1 shows the characteristics of participants of each cohort. Out of a total of 160757 mothers, 2618 125 
(1·7%) had gestational diabetes, 9755 (6·5%) had gestational hypertension, and 4836 (3·3%) had pre-126 
eclampsia. 30927 (19·7%) of the mothers were overweight and 12467 (7·9%) obese. Among offspring 127 
5606 (6·6%), 24254 ( 20·1%) and 3699 (21·3 %) were overweight in early-, mid-, and late-childhood, 128 
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respectively. Cohort-specific information on childhood age at assessment and BMI is shown in 129 
Supplemental Table S4. Figure 1 shows the percentages of childhood overweight according to their 130 
mothers pre-pregnancy BMI category and presence or absence of each pregnancy complication. The 131 
highest percentages of childhood overweight were observed in children whose mothers were overweight 132 
or obese at the start of pregnancy, independent of whether their mothers had gestational diabetes or 133 
gestational hypertensive disorders. A small increase in the percentage of childhood overweight was 134 
observed by the presence of gestational diabetes in both normal weight and overweight or obese mothers, 135 
whereas no differences were observed by presence or absence of gestational hypertensive disorders. 136 
 137 
Gestational diabetes and childhood BMI 138 
Figure 2A shows that in basic and lifestyle characteristics models, gestational diabetes was associated 139 
with a higher offspring BMI throughout childhood (differences in BMI-SDS in lifestyle characteristics 140 
models: 0·11 SDS (95% Confidence Intervals (CI) 0·06, 0·16); 0·21 SDS (95% CI 0·16, 0·26); 0·08 SDS 141 
(95% CI -0·04, 0·21) in early-, mid- and late-childhood, respectively), as compared to uncomplicated 142 
pregnancies. After additional adjustment for maternal BMI, these associations largely attenuated towards 143 
the null. Similarly, gestational diabetes was associated with increased odds of overweight throughout 144 
childhood in basic and lifestyle characteristics models, with the strongest association in early-childhood 145 
(Odds Ratio (OR) 1·59 (95% CI 1·36, 1·86) (Figure 2B). Adjustment for maternal BMI largely attenuated 146 
the effect estimates towards the null. Only the association of gestational diabetes with the odds of early 147 
childhood overweight remained significant (OR 1·35 (95% CI 1·15; 1·58)). Gestational diabetes tended to 148 
be associated with a lower odds of underweight throughout childhood in basic model (Supplemental 149 
Table S5). Additional adjustment for gestational hypertension and pre-eclampsia did not affect the 150 
observed associations of gestational diabetes with childhood outcomes (Supplemental Table S6). 151 
Although no statistical interaction was present, as sensitivity analyses, we have explored the associations 152 
of gestational diabetes with childhood BMI, stratified by maternal BMI groups and found similar 153 
associations across groups (Supplemental Table S7). Similar associations of gestational diabetes with 154 
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childhood BMI were also observed when adjusting for pre/early-pregnancy or pre-pregnancy BMI 155 
(Supplemental Table S8). 156 
 157 
Gestational hypertensive disorders and childhood BMI 158 
Figure 3A shows that, as compared to uncomplicated pregnancies, gestational hypertension was 159 
associated with a higher BMI throughout childhood in basic and lifestyle characteristics models 160 
(differences in BMI-SDS in lifestyle characteristics models: 0·07 SDS (95% CI 0·03, 0·11); 0·13 SDS 161 
(95% CI 0·10, 0·17); 0·20 SDS (95% CI 0·14, 0·27) in early-, mid- and late-childhood, respectively). 162 
These associations were partly explained by maternal BMI (difference in BMI-SDS: 0·01 SDS (95% CI - 163 
0·03, 0·06); 0·04 SDS (95% CI 0·01, 0·07); 0·07 SDS (95% CI 0·01, 0·13) in early-, mid- and late-164 
childhood, respectively). Gestational hypertension was also associated with higher odds of overweight 165 
throughout childhood. The strongest association was observed for late-childhood (OR 1·49 (95% CI 1·30, 166 
1·70)). Additional adjustment for maternal BMI largely attenuated these associations (Figure 3B). In the 167 
basic model, gestational hypertension was associated with a lower odds of childhood underweight at all 168 
ages (Supplemental Table S5).  169 
Pre-eclampsia was associated with a lower BMI in early-childhood in both basic and lifestyle 170 
characteristics models (difference in BMI-SDS in lifestyle characteristics model: - 0.05 SDS (95% CI - 171 
0·09, - 0·01)) (Figure 4A). This inverse association strengthened upon additional adjustment for maternal 172 
BMI. In contrast, we observed a positive association of pre-eclampsia with BMI in mid- and late-173 
childhood in basic and lifestyle characteristics models (differences in BMI-SDS in lifestyle characteristics 174 
models: 0·10 SDS (95% CI 0·06, 0·13); 0·16 SDS (95% CI 0·03, 0·30) in mid- and late-childhood, 175 
respectively). These associations fully attenuated after additional adjustment for maternal BMI. The 176 
associations of pre-eclampsia with overweight in mid- and late-childhood also fully attenuated after 177 
adjustment for maternal BMI (Figure 4B). In the basic model, pre-eclampsia was associated with a higher 178 
odds of underweight in early-childhood only (Supplemental Table S5). Similar associations between both 179 
gestational hypertension and pre-eclampsia with childhood outcomes were observed when adjusting for 180 
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pre/early-pregnancy or pre-pregnancy BMI (Supplemental Table S8) and when additionally adjusted for 181 
gestational diabetes (Supplemental Table S6). 182 
 183 
2-stage meta-analyses  184 
Analyses performed with 2-stage meta-analyses were consistent with those obtained from our main (1-185 
stage) meta-analyses (Supplemental Figures S2-10). We did not observe substantial heterogeneity 186 
between the cohorts in any association that we assessed (I
2
 range 0 to 40%, with 6 out of the 9 meta-187 
analyses having I
2
 <25%; Supplemental Figures S2-10).  188 
 189 
DISCUSSION 190 
Results from our IPD analysis of 160757 mothers and children from Europe and North America 191 
demonstrated that children born to mothers with gestational diabetes and gestational hypertension had a 192 
higher BMI and higher odds of being overweight throughout childhood, whereas pre-eclampsia was 193 
associated with a lower BMI in early-childhood. These associations were of small magnitude and largely 194 
explained by maternal pre/early-pregnancy BMI.  195 
 196 
Interpretation of main findings 197 
Gestational diabetes and gestational hypertensive disorders affect substantial numbers of pregnancies and 198 
are associated with adverse maternal and fetal pregnancy outcomes.
1-3
 Gestational diabetes may lead to 199 
fetal overnutrition as a result of maternal hyperglycemia during pregnancy.
7
 Gestational hypertension and 200 
pre-eclampsia are related to placental dysfunction, which may lead to impaired fetal nutrient supply.
8,30
 201 
Both conditions may subsequently induce permanent changes in offspring body composition, 202 
neuroendocrine systems and metabolic functions, which predispose offspring to an increased risk of 203 
obesity in later life.
9
 Our aim was to explore if gestational diabetes and gestational hypertensive 204 
disorders affect the risk of offspring obesity independently of the risk conferred by maternal obesity. 205 
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Disentangling the independent role of these maternal pregnancy complications on childhood obesity risk 206 
is important for development of future childhood obesity prevention strategies.  207 
 Results from two systematic reviews of 12 and 9 published cohort studies suggested that maternal 208 
diabetes during pregnancy was associated with a higher offspring BMI . These associations were no 209 
longer present in single studies that adjusted for maternal pre-pregnancy BMI.
14,31
 Recently, several 210 
prospective observational studies reported inconsistent findings for the association of gestational diabetes 211 
with offspring BMI after adjustment for maternal BMI.
11-13,15-17,32-34
 An older prospective cohort study of 212 
280866 Swedish men recruited from 1973 to 1988, suggested that diabetes during pregnancy, including 213 
gestational diabetes and pre-existing diabetes, was associated with a higher BMI at the age of 18 years. 214 
This association was independent of maternal BMI.
17
 In contrast, we observed that children of mothers 215 
with gestational diabetes had a higher BMI throughout childhood, but this association was largely 216 
explained by maternal pre/early-pregnancy BMI. This different finding might be explained by 217 
methodological differences between our IPD meta-analysis and the Swedish Study, as the Swedish study 218 
was focused on men only, measured offspring BMI in adulthood, and does not reflect contemporary 219 
clinical practice which involves newer screening and treatment strategies. We observed the strongest 220 
association of gestational diabetes with offspring obesity in early-childhood. This may be explained by 221 
tracking of birth size.
35,36
 Consistent with our findings, treatment of gestational diabetes, defined as a 222 
fasting glucose <95 mg/dL and two of three timed measurements that exceeded established thresholds, 223 
was found to be beneficial for neonatal outcomes, but did not influence offspring obesity risk at age 5-10 224 
years in a multicenter randomized controlled trial.
37
 Using the diagnosis of gestational diabetes may 225 
insufficiently reflect glycemic status during pregnancy. Maternal glucose levels below current diagnostic 226 
criteria of diabetes, are linearly and positively associated with adverse perinatal outcomes.
35,38
 However, 227 
several studies showed that maternal gestational glucose was not associated with offspring BMI in early 228 
childhood, after adjustment for maternal BMI.
39,40
 Thus, our findings strongly suggest that the association 229 
of gestational diabetes with higher BMI in the offspring is largely explained by maternal BMI. 230 
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Few studies have examined the association of gestational hypertensive disorders with childhood 231 
adiposity. Data from a UK prospective cohort study of 6343 mother-offspring pairs found a positive 232 
association of gestational hypertension with childhood adiposity at age 9, which attenuated after 233 
adjustment for parental BMI.
18
 This study also found inverse associations of pre-eclampsia with offspring 234 
lean mass and adiposity at age 9 after adjustment for parental BMI.
18
 In contrast, an Australian cohort 235 
study of 1151 mother-offspring pairs born at term showed that offspring of mothers with gestational 236 
hypertension had higher risk of overweight at 20 years, independently of maternal BMI.
19
 No association 237 
of pre-eclampsia with offspring BMI was present.
19
 We observed that gestational hypertension was 238 
associated with a higher BMI and odds of overweight throughout childhood, but this association was also 239 
largely explained by maternal BMI. Pre-eclampsia was associated with a lower BMI in early-childhood, 240 
and this inverse association was stronger after adjustment for maternal BMI. In later childhood, pre-241 
eclampsia was associated with a higher childhood BMI, but this association was no longer present after 242 
adjustment for maternal BMI. This might be explained by a smaller size at birth among children of 243 
mothers with pre-eclampsia due to placental dysfunction and fetal growth restriction.
41
 These children 244 
might experience accelerated growth in infancy and early-childhood, leading to higher BMI in mid- and 245 
late-childhood.
42
 Further studies using detailed assessment of maternal blood pressure and placental 246 
function, which provides details on disease severity, may provide more insight into the effects of pre-247 
eclampsia on childhood adiposity development.  248 
Our observations are important from an etiological and preventive perspective. The associations 249 
of gestational diabetes and gestational hypertensive disorders with offspring obesity were of limited 250 
clinical importance and largely dependent on maternal BMI. Interventions to reduce the risk of pregnancy 251 
complications or improve the effectiveness of their treatment may be important in relation to a range of 252 
problems for the mother and child, but they are unlikely to influence directly the development of obesity 253 
in offspring.  254 
 255 
Strengths and limitations  256 
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Major strengths of our study are the large sample of contemporary populations reflecting current 257 
diagnosis and treatment policies and the use of IPD from a wide selection of existing studies to reduce the 258 
risk of publication bias. We were able to adjust for multiple confounders, with a particular focus on 259 
maternal pre-pregnancy BMI. Out of 50 cohorts identified and invited, 38 agreed to participate and 34 260 
were included in these analyses. Only 4 cohorts (113417 participants) were excluded due to missing data 261 
on exposures and/or outcomes. Bias in our findings is unlikely since the reasons for not participating are 262 
not related to the research question of the study but rather to study design or follow-up. Although we have 263 
included cohorts from early 1990´s onwards, the study period does not seem to influence our findings 264 
since we observed low heterogeneity between all cohorts in the associations assessed. We included data 265 
from cohort studies from Europe and North America, so our findings are mainly applicable for Western 266 
populations. The inclusion of data from other regions could have led to large differences in maternal and 267 
childhood obesity prevalences, treatment of pregnancy complications and ethnic and sociodemographic 268 
characteristics, complicating or limiting the possibility to meta-analyse the data. Further studies are 269 
needed to assess these associations among populations from low- and middle-income countries, and to 270 
explore potential differences among women from different ethnic backgrounds known to be at higher risk 271 
to develop pregnancy complications. Within some cohorts, women might have participated with multiple 272 
singleton pregnancies. We were unable to account for within-mother clustering, as this data was not 273 
available within our IPD meta-analysis. However, as this only reflects a very small number of women, we 274 
consider it unlikely that this has affected our results. Our observed associations are applicable for 275 
singleton pregnancies. As important differences in placental development and function, fetal nutrient 276 
supply and growth are present among twin pregnancies, further studies are needed to explore whether 277 
these findings are also present among twin pregnancies. We are aware that our study cannot overcome 278 
potential limitations of individual studies in terms of their design and conduct, differences in 279 
measurements and definitions of exposure and outcome data, variation in missing data and loss to follow 280 
up. Some cohorts relied on self-reporting to obtain information on pregnancy complications. We were not 281 
able to perform sensitivity analyses based on the methods of data collection since some cohorts have 282 
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collected data on pregnancy complications using more than one method. Misclassification of women, if 283 
present, might have led to attenuation of the associations. The prevalence of gestational diabetes in our 284 
sample was relatively low and varied substantially between cohorts, which might suggest 285 
underascertainment of this condition, differences in screening protocols between cohorts and a selection 286 
towards a relatively healthy study population. This might affect the generalizability of our findings. We 287 
have no information on how any of the pregnancy complications were treated, which might also differ per 288 
cohort. Effective treatment that reduced circulating glucose and blood pressure during pregnancy may 289 
lead to weaker associations of these conditions with offspring obesity. Given that our IPD meta-analysis 290 
includes contemporary cohorts reflecting contemporary screening and treatment protocols, it seems likely 291 
that a large number of women received treatment for the pregnancy complication. Self-reported maternal 292 
pre-pregnancy BMI might also be a source of bias. However, a systematic review showed that reporting 293 
error did not bias associations between pregnancy-related weight and birth outcomes
43
, suggesting that 294 
bias due to self-reported maternal BMI is unlikely in our results. If pre-pregnancy BMI was not available, 295 
we used early-pregnancy BMI, which might have overestimated BMI as a result of gestational weight 296 
gain. However, similar results were observed when restricting the analyses to the participants with 297 
information on pre-pregnancy BMI. Most cohorts have relied on measured childhood weight and height 298 
and therefore bias based on self-reported weight and height is unlikely. We did not perform mediation 299 
analyses, which we consider beyond the scope of this manuscript. However, based on our findings, a 300 
mediating role of pregnancy complications in the associations of maternal BMI with childhood BMI 301 
seems unlikely. Further studies are needed to explore which pregnancy, birth, genetic or lifestyle 302 
characteristics mediate the associations of maternal BMI with childhood BMI. Missing values of 303 
covariates were used as an additional group, which might not be optimal, but is a method commonly used 304 
in large IPD meta-analyses.
44
 Finally, due to the observational design, residual confounding cannot be 305 
excluded.  306 
 307 
Conclusions  308 
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The associations of gestational diabetes, gestational hypertension and pre-eclampsia with childhood 309 
obesity are largely explained by maternal pre/early-pregnancy BMI. These findings from a large 310 
international IPD meta-analysis of contemporary cohorts are important for future public health strategies 311 
on childhood obesity. Interventions focused on prevention or treatment of these pregnancy complications, 312 
though important for other maternal and fetal pregnancy outcomes, are unlikely to have a direct impact on 313 
offspring BMI.  314 
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Table 1. Characteristics of the participating pregnancy and birth cohorts (n=160757)
a,b
  
Cohort name,  
number of participants, 
birth years (country) 
Gestational 
diabetes 
Gestational 
hypertension 
Pre-
eclampsia 
Early childhood (2·0-4·9y) Mid childhood (5·0-9·9y) Late childhood (10·0-17·9y) 
Body mass 
index (SDS) 
Overweight 
and obesity 
Body mass 
index (SDS) 
Overweight 
and obesity 
Body mass 
index (SDS) 
Overweight 
and obesity 
ABCD, n=5512, 2003-2004 
(The Netherlands) 
120 (2·2) 1045 (19·0) 233 (4·2) 0·3 (-1·5, 2·4) 213 (4·5) 0·1 (-1·7, 2·4) 768 (17·1) NA NA 
ALSPAC, n=9041, 1991-
1992 (United Kingdom) 
77 (0·9) 1282 (14·5) 170 (1·9) 0·6 (-1·0, 2·5) 77 (6·5) 0·2 (-1·6, 2·7) 2113 (26·4) 0·2 (-1·9, 2·5) 2063 (26·4) 
AOB/F, n=1672, 
2008-2010 (Canada) 
71 (4·2) 118 (7·1) 104 (6·2) 0·2 (-2·3, 2·7) 96 (5·7) NA NA NA NA 
BAMSE, n=3329,  
1994-1996 (Sweden) 
56 (1·7) NA 55 (1·7) 0·6 (-0·9, 2·5) 187 (6·5) 0·5 (-1·2, 2·6) 799 (31·2) 0·1 (-1·7, 2·0) 425 (16·9) 
BIB, n=983, 2007-2010 
(United Kingdom) 
100 (10·2) 51 (5·3) 13 (1·4) 0·5 (-1·4, 2·6) 74 (7·5) NA NA NA NA 
Co.N.ER, n=528,  
2004-2005 (Italy) 
14 (2·7) 20 (3·8) 12 (2·3) 0·3 (-2·3, 2·9) 47 (9·7) 0·7 (-1·3, 2·9) 102 (35·5) NA NA 
DNBC, n=40349,  
1996-2002 (Denmark) 
273 (0·7) 1878 (4·7) 1380 (3·4) NA NA 0 (-1·9, 2·1) 6304 (15·6) NA NA 
EDEN, n=1361,  
2003-2005 (France) 
92 (6·8) 67 (4·9) 30 (2·2) 0·3 (-1·4, 2·0) 27 (2·2) 0 (-1·5, 2·0) 147 (12·9) NA NA 
FCOU, n=2332,  
1993-1996 (Ukraine) 
5 (0·2) 367 (15·7) 148 (6·3) 0·5 (-1·9, 3·1) 140 (10·6) 0 (-2·0, 2·0) 124 (12·6) -0·1 (-2·0, 1·8) 75 (8·9) 
GASPII, n=570,  
2003-2004 (Italy) 
25 (4·4) 28 (4·9) 5 (0·9) 0·7 (-1·1, 2·9) 52 (9·7) 0·7 (-1·4, 2·7) 172 (37·1) NA NA 
GECKO Drenthe, n=2119, 
2006-2007  
(The Netherlands) 
72 (3·4) 209 (11·0) 46 (2·4) NA NA 0·4 (-1·2, 2·4) 465 (21·9) NA NA 
GENESIS, n=2143,  
2003-2004 (Greece) 
30 (1·4) NA NA 0·8 (-1·2, 3·6) 297 (14·6) 1·0 (-1·5, 3·9) 45 (42·1) NA NA 
GENERATION R, n=7550, 
2002-2006 
 (The Netherlands) 
80 (1·1) 274 (4·0) 149 (2·3) 0·3 (-1·5, 2·5) 220 (5·1) 0·3 (-1·5, 2·7) 1849 (27·4) 0·4 (-1·5, 2·6) 160 (30·0) 
GENERATION XXI, 
n=5921,  
2005-2006 (Portugal) 
390 (6·6) 135 (2·3) 90 (1·5) 0·5 (-1·3, 3·1) 485 (10·4) 0·6 (-1·4, 3·2) 2015 (38·0) NA NA 
GINIplus, n=2313,  
1995-1998 (Germany) 
61 (2·6) NA NA 0·1 (-1·7, 2·0) 53 (2·4) 0 (-1·8, 1·9) 227 (10·6) 0 (-1·9, 2·1) 365 (16·0) 
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Table 1. Characteristics of the participating pregnancy and birth cohorts (n=160757)
a
 (continued) 
Cohort name, 
number of participants, 
birth years (country) 
Gestational 
diabetes 
Gestational 
hypertension 
Pre-
eclampsia 
Early childhood (2·0-4·9 y) Mid childhood (5·0-9·9y) Late childhood (10·0-17·9y) 
Body mass 
index (SDS) 
Overweight 
and obesity 
Body mass 
index (SDS) 
Overweight 
and obesity 
Body mass 
index (SDS) 
Overweight 
and obesity 
HUMIS, n=970,  
2003-2008 (Norway) 
5 (0·5) 37 (3·8) 70 (7·2) 0·3 (-1·8, 2·4) 53 (6·0) 0·0 (-2·0, 2·3) 63 (17·6) NA NA 
INMA, n=1933,  
1997-2008 (Spain) 
191 (11·3) 58 (3·0) 4 (0·9) 0·5 (-1·2, 2·8) 143 (8·2) 0·6 (-1·4, 3·3) 503 (37·6) 0·3 (-1·6, 2·5) 79 (25·3) 
KOALA, n=2061, 2000-
2002 (The Netherlands) 
21 (1·0) 72 (3·5) 26 (1·3) -0·1 (-2·0, 1·9) 17 (1·7) -0·2 (-2·2, 1·8) 199 (11·3) -0·2 (-2·1, 2·2) 19 (18·1) 
Krakow Cohort, n=424, 
2000-2003 (Poland) 
18 (4·2) 19 (4·5) 0 (0·0) 0 (-2·2, 2·3) 11 (4·1) 0·2 (-1·8, 2·6) 90 (26·5) NA NA 
LISAplus, n=1584,  
1997-1999 (Germany) 
58 (3·7) NA NA 0 (-1·7, 1·9) 33 (2·3) -0·1 (-1·8, 1·8) 140 (9·9) 0 (1·8, 2·1) 236 (15·2) 
MoBa, n=55008,  
1999-2009 (Norway) 
418 (0·8) 3131 (5·7) 2023 (3·7) 0·4 (-1·8, 2·5) 2456 (6·1) 0·1 (-2·0, 2·3) 6793 (19·5) NA NA 
NINFEA
b
, n=1726,  
2005-2010 (Italy) 
132 (7·7) 136 (7·9) 44 (2·6) 0·1 (-2·3, 2·5) 86 (5·1) 0 (-2·2, 2·4) 90 (21·2) NA NA 
PÉLAGIE, n=738,  
2002-2005 (France) 
21 (2·8) 24 (3·3) 8 (1·1) 0·1 (-1·8, 1·9) 15 (2·0) NA NA NA NA 
PIAMA, n=1815, 1996-
1997 (The Netherlands) 
19 (1·0) 179 (9·9) 46 (2·5) 0·7 (-1·2, 2·5) 78 (8·9) 0·1 (-1·6, 2·4) 325 (20·0) -0·2 (-1·7, 1·8) 77 (10·0) 
Piccolipiù, n=687,  
2011-2015 (Italy)  
69 (10·1) 24 (3·5) 6 (0·9) 0·3 (-2·1, 2·5) 40 (5·8) NA NA NA NA 
Project Viva, n=1389, 
1999-2002 (United States) 
64 (4·7) 85 (6·3) 46 (3·4) 0·7 (-1·0, 2·7) 87 (7·1) 0·4 (-1·4, 3·0) 328 (30·8) 0·4 (-1·5, 3·7) 8 (25·8) 
REPRO_PL, n=291, 
2007-2011 (Poland) 
13 (4·5) 17 (5·8) 0 (0·0) 0·3 (-2·2, 2·5) 19 (6·9) 0·6 (-1·5, 3·6) 19 (38·8) NA NA 
RHEA, n=740, 
2007-2008 (Greece) 
60 (8·8) 35 (5·2) 5 (0·7) 0·6 (-1·1, 3·6) 91 (12·3) NA NA NA NA 
ROLO, n=283,  
2007-2011 (Ireland) 
10 (3·5) NA NA 0·2 (-1·7, 2·6) 19 (6·7) NA NA NA NA 
SCOPE BASELINE, 
n=1046, 2008-2011 
(Ireland) 
NA 129 (12·3) 35 (3·3) 0·6 (-1·0, 2·3) 62 (5·9) NA NA NA NA 
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Table 1. Characteristics of the participating pregnancy and birth cohorts (n=160757)
a
 (continued) 
 
a
Values are expressed as medians (95% range) or numbers of subjects (valid %). NA, not available. 
b
 Subset of participants with follow-up completed at 4 years of child’s age by the time of data transfer (March 2015)
Cohort name, 
number of participants, 
birth years (country) 
Gestational 
diabetes 
Gestational 
hypertension 
Pre-
eclampsia 
Early childhood (2·0-4·9 y) Mid childhood (5·0-9·9y) Late childhood (10·0-17·9y) 
Body mass 
index (SDS) 
Overweight 
and obesity 
Body mass 
index (SDS) 
Overweight 
and obesity 
Body mass 
index (SDS) 
Overweight  
and obesity 
SEATON, n=872, 1998-
1999 (United Kingdom) 
NA 119 (13·9) 16 (2·1) 0·7 (-0·9, 2·7) 36 (8·1) 0·6 (-1·1, 2·8) 55 (19·8) 0·4 (-1·6, 2·6) 192 (32·9) 
Slovak PCB study, n=524, 
2002-2004 (Slovakia) 
3 (0·6) 54 (12·4) NA 1·9 (-2·4, 5·3) 222 (48·2) 0·3 (-1·7, 3·3) 123 (31·0) NA NA 
STEPS, n=297, 2008-2010 
(Finland) 
20 (6·7) NA NA 0·5 (-1·2, 2·2) 13 (4·4) NA NA NA NA 
SWS, n=2646, 1998-2007 
(United Kingdom) 
30 (1·1) 162 (6·1) 72 (2·7) 0·5 (-1·3, 2·6) 157 (6·2) 0·2 (-1·5, 2·5) 396 (22·0) NA NA 
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Figure 1. Percentages of childhood overweight according to maternal pre-pregnancy BMI category and 
presence or absence of A. gestational diabetes, B. gestational hypertension, and C. pre-eclampsia. 
A.  
      
 
B.  
      
 
C.  
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Figure 2. Associations of gestational diabetes with offspring BMI outcomes in early, mid, and late 
childhood.
a 
 
 
 
 
 
a
Values are regression coefficients (95% confidence intervals) from multilevel linear mixed effects models and odds 
ratios (95% confidence intervals) from multilevel binary logistic models that reflect differences in early childhood 
(2·0 to 4·9 years), mid childhood (5·0 to 9·9 years) and late childhood (10·0 to 17·9 years) BMI SDS and risk of 
overweight and obesity, respectively, for children born to mothers with gestational diabetes, as compared with the 
reference group (children born to mothers with an uncomplicated pregnancy). Lifestyle characteristics models are 
adjusted for offspring’s sex, maternal age, educational level, ethnicity, parity, and smoking during pregnancy. 
Maternal BMI models are additionally adjusted for maternal pre/early-pregnancy BMI. 
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Figure 3. Associations of gestational hypertension with offspring BMI outcomes in early, mid, and late 
childhood.
a 
 
 
 
 
 
a
Values are regression coefficients (95% confidence intervals) from multilevel linear mixed effects models and odds 
ratios (95% confidence intervals) from multilevel binary logistic models that reflect differences in early childhood 
(2·0 to 4·9 years), mid childhood (5·0 to 9·9 years) and late childhood (10·0 to 17·9 years) BMI SDS and risk of 
overweight and obesity, respectively, for children born to mothers with gestational hypertension, as compared with 
the reference group (children born to mothers with an uncomplicated pregnancy). Lifestyle characteristics models 
are adjusted for offspring’s sex, maternal age, educational level, ethnicity, parity, and smoking during pregnancy. 
Maternal BMI models are additionally adjusted for maternal pre/early-pregnancy BMI. 
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Figure 4. Associations of pre-eclampsia with offspring BMI outcomes in early, mid, and late childhood.
a 
 
 
 
 
 
a
Values are regression coefficients (95% confidence intervals) from multilevel linear mixed effects models and odds 
ratios (95% confidence intervals) from multilevel binary logistic models that reflect differences in early childhood 
(2·0 to 4·9 years), mid childhood (5·0 to 9·9 years) and late childhood (10·0 to 17·9 years) BMI SDS and risk of 
overweight and obesity, respectively, for children born to mothers with pre-eclampsia, as compared with the 
reference group (children born to mothers with an uncomplicated pregnancy). Lifestyle characteristics models are 
adjusted for offspring’s sex, maternal age, educational level, ethnicity, parity, and smoking during pregnancy. 
Maternal BMI models are additionally adjusted for maternal pre/early-pregnancy BMI. 
 
